38th annual meeting of the European Thyroid Association

Dr Steve Hyer presented a paper entitled “Clinical outcomes of Graves’ disease using a targeted absorbed dose of 60 Gy 131I to the thyroid.” Co-authors were B. Pratt, M. Gray, Dr Newbold, Dr Flux and Dr Harmer. The study reported the long term benefits of an individualized dose of radioiodine.